Submissions for variant NM_000540.3(RYR1):c.8518C>T (p.Arg2840Trp)

gnomAD frequency: 0.00001  dbSNP: rs193922830

Total submissions: 6

Submitter	RCV	SCV	Clinical significance	Condition	Last evaluated	Review status	Method	Comment
ClinGen Malignant Hyperthermia Susceptibility Variant Curation Expert Panel, ClinGen	RCV001802882	SCV002047634	uncertain significance	Malignant hyperthermia of anesthesia	2023-04-06	reviewed by expert panel	curation	This pathogenicity assessment is relevant only for malignant hyperthermia susceptibility (MHS) inherited in an autosomal dominant pattern. Variants in RYR1 can also cause other myopathies inherited in an autosomal dominant pattern or in an autosomal recessive pattern. Some of these disorders may predispose individuals to malignant hyperthermia. RYR1 variants may also contribute to a malignant hyperthermia reaction in combination with other genetic and non-genetic factors and the clinician needs to consider such factors in making management decisions. This sequence variant predicts a substitution of arginine with tryptophan at codon 2840 of the RYR1 protein, p.(Arg2840Trp). The maximum allele frequency for this variant among the six major gnomAD populations is SAS: 0.000131, a frequency consistent with pathogenicity for MHS. This variant has been reported in an individual with a personal or family history of an MH episode without a positive in vitro contracture test (IVCT) or caffeine halothane contracture test (CHCT) result (if the proband was unavailable for testing, a positive diagnostic test result in a mutation-positive relative was counted), PS4 not implemented (PMID:16732084). No functional studies were identified for this variant. This variant does not reside in a hotspot for pathogenic variants that contribute to MHS. A REVEL score of 0.659 supports neither a pathogenic nor a benign status for this variant. This variant has been classified as a Variant of Unknown Significance. No criteria implemented.
Labcorp Genetics (formerly Invitae), Labcorp	RCV000810497	SCV000950700	uncertain significance	RYR1-related disorder	2022-05-19	criteria provided, single submitter	clinical testing	This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 2840 of the RYR1 protein (p.Arg2840Trp). This variant is present in population databases (rs193922830, gnomAD 0.01%). This missense change has been observed in individual(s) with malignant hyperthermia (PMID: 16732084, 16917943). ClinVar contains an entry for this variant (Variation ID: 133226). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR1 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics	RCV001839447	SCV002099528	likely pathogenic	Central core myopathy	2021-10-02	criteria provided, single submitter	clinical testing	A heterozygous missense variation in exon 54 of the RYR1 gene that results in the amino acid substitution of Tryptophan for Arginine at codon 2840 was detected. The observed variant c.8518C>T (p.Arg2840Trp) has not been reported in the 1000 genomes and has minor allele frequency of 0.001% gnomAD database. The in silico prediction of the variant are possibly damaging by PolyPhen-2 (HumDiv) and damaging by MutationTaster2 and SIFT. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as a likely pathogenic variant.
Fulgent Genetics, Fulgent Genetics	RCV002505056	SCV002816052	uncertain significance	Central core myopathy; Malignant hyperthermia, susceptibility to, 1; Congenital multicore myopathy with external ophthalmoplegia; Congenital myopathy with fiber type disproportion; King Denborough syndrome	2021-08-27	criteria provided, single submitter	clinical testing
All of Us Research Program, National Institutes of Health	RCV003997323	SCV004823215	uncertain significance	Malignant hyperthermia, susceptibility to, 1	2023-05-31	criteria provided, single submitter	clinical testing
Leiden Muscular Dystrophy (RYR1)	RCV000119749	SCV000154656	not provided	not provided		no assertion provided	not provided